The Quiet Revolution: How Small Biotechs are Outpacing Big Pharma
In 2024, biotech firms were responsible for nearly two-thirds of new drug approvals by the U.S. FDA. Smaller biotechs are increasingly choosing market independence, challenging traditional Big Pharma dominance. Advancements…
Why Genenta Science’s Strategic Moves Could Turn Heads in Biotech Investment Circles
Genenta Science is set to present at the 'Montalcini Global Biotech Tour' in Doha on April 17th, 2025, aiming to expand investment opportunities beyond traditional western markets. The firm secured…
Why the Security of Biotechnology Infrastructure Is Critical to National Defense
Biotechnology's infrastructure is crucial for innovation in health and agriculture but lacks adequate national security protection. The National Security Commission on Emerging Biotechnology urges classifying biotechnology alongside critical sectors like…
Inside the Cash Conundrum: Can IO Biotech Survive the Burn?
IO Biotech faces critical financial decisions as its cash reserves deplete, having $60 million at the start of December 2024 but burning $82 million annually. The company’s cash burn rate…
The Biotech Boom: Why These Under-the-Radar Stocks Are Catching Investors’ Eyes
A surge in online search activity highlights growing investor interest in biotech companies. Biotie Therapies is at the forefront, focusing on transformative treatments for central nervous system disorders such as…
Can the U.S. Hold Its Ground as China Surges in Biotechnology?
The global biotechnology race is intensifying, with the U.S. and China competing for dominance, impacting national security, economic balance, and technological progress. The National Security Commission on Emerging Biotechnology warns…
The Behind-the-Scenes Project Transforming U.S. Biotech Strategy to Challenge China
The U.S. is positioning itself as a leader in biotechnology through a strategic push championed by Senator Todd Young. Young's proposal suggests unifying various federal agencies to align under a…
This Startup Is Transforming the Future of Food with a Radically New Ingredient
Nourish Ingredients has introduced Tastilux®, a precision-fermented fat replicating real meat's savor without using animal products. Partnered with CABIO Biotech, they achieved large-scale production at reduced costs, underscoring commercial viability.…
The Return of the Dire Wolf: How Sci-Fi Became Reality Through De-Extinction
Colossal Biosciences has achieved a groundbreaking scientific milestone by resurrecting the dire wolf, extinct for over 10,000 years. Named Romulus and Remus, these creatures symbolize the fusion of modern genetics…
Unveiling the Future of Immunotherapy: What Evaxion Biotech’s Bold Moves Mean for the Market
Evaxion Biotech A/S is preparing transformative proposals for its Annual General Meeting on April 30, 2025, focusing on reshaping its identity and financial strength. The company specializes in AI-driven therapies…